A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer

University of California San Diego Moores Cancer Center, La Jolla

UCLA School of Medicine, Division of Hematology-Oncology, Los Angeles

UC Irvine Medical Center, Orange

University of Colorado Health Science Center Facility, Denver

Georgetown, MedStar Research Institute, Washington D.C.

H. Lee Moffitt Cancer Center & Research Institute, Tampa

Tampa General Hospital, Tampa

Winship Cancer Center, Emory University, Atlanta

The Universtiy of Chicago Medical Center, Chicago

St. James Hospital and Health Centers Comprehensive Cancer Institute, Olympia Fields

Indiana University Medical Goup, Indianapolis

Johns Hopkins Medical Center, Baltimore

Beth Israel Deaconess Medical Center, Boston

Wayne State University, Karmanos Cancer Institute, Detroit

Research Medical Center, Kansas City

Washington University, St Louis

Beth Israel Medical Center, BI Cancer Center, New York

Leo W. Jenkins Cancer Center, Greenville

Cancer Centers of the Carolinas, Greenville

Mary Crowley Medical Center, Dallas

Univeristy of Texas Southwestern Medical Center, Dallas

Baylor College of Medicine, Houston

Virginia Commonwealth University, Richmond

Virginia Mason Medical Center, Seattle

University of Wisconsin, Division of Neoplastic Diseases & Related Disorders, Milwaukee